[go: up one dir, main page]

NO20080045L - Glykosylert UL-7, fremstilling og anvendelse av samme - Google Patents

Glykosylert UL-7, fremstilling og anvendelse av samme

Info

Publication number
NO20080045L
NO20080045L NO20080045A NO20080045A NO20080045L NO 20080045 L NO20080045 L NO 20080045L NO 20080045 A NO20080045 A NO 20080045A NO 20080045 A NO20080045 A NO 20080045A NO 20080045 L NO20080045 L NO 20080045L
Authority
NO
Norway
Prior art keywords
polypeptides
well
relates
preparation
same
Prior art date
Application number
NO20080045A
Other languages
English (en)
Other versions
NO344802B1 (no
Inventor
Brigitte Assouline
Michel Morre
Iann Rance
Anne Gregoire
Corinne Breque
Original Assignee
Cytheris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytheris filed Critical Cytheris
Publication of NO20080045L publication Critical patent/NO20080045L/no
Publication of NO344802B1 publication Critical patent/NO344802B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5418—IL-7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Sammendrag Det beskrives nye og forbedrete interl eukin-7 polypeptider, og likeledes sammensetninger omfattende samme, deres framstilling og anvendelser. Nærmere bestemt vedrører oppfinnelsen hyperglykosylerte IL-7 polypeptider som har forbedrete egenskaper, og likeledes framstilling og terapeutiske anvendelser av disse. Oppfinnelsen beskriver også nye IL-7 polypeptider som har modifiserte aminosyresekvenser inne- holdende artifisielt etablerte glykosyleringssete(r), og likeledes korresponderende nukleinsyremolekyler, vektorer og rekombinante vertsceller. Oppfinnelsen vedrører også anvendelse av slike polypeptider, celler eller nukleinsyrer for helbredende eller preventiv behandling av mammaiske individer, inkluderende mennesker.
NO20080045A 2005-07-20 2008-01-03 Glykosylert UL-7, fremstilling og anvendelse av samme. NO344802B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05291556A EP1746161A1 (en) 2005-07-20 2005-07-20 Glycosylated IL-7, preparation and uses
PCT/IB2006/002663 WO2007010401A2 (en) 2005-07-20 2006-07-19 Glycosylated il-7, preparation and uses

Publications (2)

Publication Number Publication Date
NO20080045L true NO20080045L (no) 2008-04-21
NO344802B1 NO344802B1 (no) 2020-05-04

Family

ID=35385570

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080045A NO344802B1 (no) 2005-07-20 2008-01-03 Glykosylert UL-7, fremstilling og anvendelse av samme.

Country Status (19)

Country Link
US (3) US7708985B2 (no)
EP (2) EP1746161A1 (no)
JP (2) JP5685363B2 (no)
CN (2) CN101228275B (no)
AT (1) ATE542901T1 (no)
AU (1) AU2006271315B2 (no)
CA (2) CA2859145C (no)
CY (1) CY1112655T1 (no)
DK (1) DK1904635T3 (no)
EA (1) EA012802B1 (no)
ES (1) ES2379732T3 (no)
IL (1) IL188480A0 (no)
NO (1) NO344802B1 (no)
NZ (1) NZ564907A (no)
PL (1) PL1904635T3 (no)
PT (1) PT1904635E (no)
SI (1) SI1904635T1 (no)
WO (1) WO2007010401A2 (no)
ZA (1) ZA200800533B (no)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1324779B1 (en) 2000-09-29 2011-07-20 Schering Corporation Pegylated interleukin-10
EP1391513A1 (en) * 2002-08-08 2004-02-25 Cytheris IL-7 drug substance, IL-7 comprising composition, preparation and uses thereof
AU2004309050B2 (en) 2003-12-30 2010-10-14 Merck Patent Gmbh IL-7 fusion proteins
EP2468293B1 (en) 2006-09-28 2014-10-22 Merck Sharp & Dohme Corp. Use of pegylated il-10 to prevent metastasis of a cancer or tumor to the lung
PE20081250A1 (es) * 2006-11-28 2008-10-07 Centelion FUSIONES Fc CON RECEPTOR PARA FGF SOLUBLE MODIFICADAS, CON ACTIVIDAD BIOLOGICA MEJORADA
CN101943688B (zh) * 2009-07-10 2013-01-02 复旦大学 一种利用质谱靶板富集糖基化肽段的方法
JP2013534515A (ja) 2010-06-01 2013-09-05 モナシュ ユニバーシティ プロセシングされていない受容体型チロシンキナーゼｃ−ＭＥＴに対する抗体
ES2629850T3 (es) * 2010-07-19 2017-08-16 Otago Innovation Limited Biomarcadores de señal
NZ609567A (en) 2010-11-05 2015-05-29 Transbio Ltd Markers of endothelial progenitor cells and uses thereof
CA2820956C (en) 2010-12-10 2016-05-03 University Of Central Florida Research Foundation, Inc. Methods and compositions comprising il-7 receptor ligands
US20140377218A1 (en) 2011-08-03 2014-12-25 Cytheris Hcv immunotherapy
CN105209054A (zh) 2013-04-18 2015-12-30 阿尔莫生物科技股份有限公司 使用白细胞介素-10治疗疾病和病症的方法
EP3434277A1 (en) 2013-06-17 2019-01-30 Armo Biosciences, Inc. Method for assessing protein identity and stability
EP3068425B1 (en) 2013-11-11 2021-01-27 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
CN104725484B (zh) * 2013-12-19 2018-03-13 中国科学院微生物研究所 一种糖基化多肽及其制备方法和其应用
US20180028593A1 (en) 2014-03-21 2018-02-01 Boreal Invest Terminal nanofiltration of solubilized protein compositions for removal of immunogenic aggregates
US10293043B2 (en) 2014-06-02 2019-05-21 Armo Biosciences, Inc. Methods of lowering serum cholesterol
EP3209320B1 (en) 2014-10-22 2023-03-08 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
CN104372021A (zh) * 2014-11-05 2015-02-25 太仓思源生物医药有限公司 人白细胞介素-2蛋白质的制备方法
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
HK1246201A1 (zh) 2015-05-28 2018-09-07 Armo Biosciences, Inc. 用於治疗癌症的聚乙二醇化白细胞介素-10
HK1256149A1 (zh) * 2015-06-11 2019-09-13 格纳西尼有限公司 经修饰的白细胞介素-7蛋白及其用途
EP3365363A1 (en) 2015-10-23 2018-08-29 Apogenix AG Single-chain gitr-receptor agonist proteins
KR102386735B1 (ko) 2015-11-06 2022-04-14 주식회사 제넥신 변형된 인터루킨-7 융합 단백질의 제형
TWI774651B (zh) * 2015-12-04 2022-08-21 南韓商吉耐森股份有限公司 包含融合有免疫球蛋白Ｆｃ之介白素-７的用於預防或治療人類乳頭狀瘤病毒相關疾病的藥學組成物
CN108697764A (zh) 2015-12-04 2018-10-23 格纳西尼有限公司 含有免疫球蛋白fc融合白细胞介素-7融合蛋白的用于预防或治疗流感病毒感染的药物组合物
CN107759697B (zh) * 2016-08-19 2023-03-24 安源医药科技（上海）有限公司 制备融合蛋白的方法
EP4512469A3 (en) 2017-09-11 2025-05-21 Monash University Binding proteins to the human thrombin receptor, par4
CN110352202A (zh) * 2018-01-25 2019-10-18 天境生物 抗pd-l1抗体和il-7融合蛋白
EP3880231A1 (en) 2018-11-16 2021-09-22 NeoImmuneTech, Inc. Method of treating a tumor with a combination of il-7 protein and an immune checkpoint inhibitor
US20230071889A1 (en) 2018-12-21 2023-03-09 Ose Immunotherapeutics Bifunctional anti-pd-1/il-7 molecule
JP2022545184A (ja) * 2019-08-22 2022-10-26 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア アンジェルマン症候群の処置のためのｕｂｅ３ａ
KR102402276B1 (ko) * 2019-11-15 2022-05-26 주식회사 제넥신 변형된 인터루킨-7 및 tgf 베타 수용체 ii를 포함하는 융합단백질 및 이의 용도
AU2021207586A1 (en) 2020-01-13 2022-07-21 Neoimmunetech, Inc. Method of treating a tumor with a combination of IL-7 protein and a bispecific antibody
KR20220137630A (ko) 2020-02-05 2022-10-12 워싱턴 유니버시티 Il-7 단백질과 car-보유 면역 세포의 조합물로 고형 종양을 치료하는 방법
US20230398184A1 (en) 2020-10-26 2023-12-14 Neoimmunetech, Inc. Methods of inducing stem cell mobilization
WO2022094475A1 (en) 2020-11-02 2022-05-05 Neoimmunetech, Inc. Use of interleukin-7 for the treatment of coronavirus
IL302482A (en) 2020-11-05 2023-06-01 Neoimmunetech Inc Method of treating a tumor with a combination of an il-7 protein and a nucleotide vaccine
WO2022117569A1 (en) 2020-12-02 2022-06-09 Oncurious Nv A ccr8 antagonist antibody in combination with a lymphotoxin beta receptor agonist antibody in therapy against cancer
CN113817043B (zh) * 2021-09-22 2023-07-25 清华大学 制备活性铁调节激素的方法
US20250099542A1 (en) 2021-12-30 2025-03-27 Neoimmunetech, Inc. Method of treating a tumor with a combination of il-7 protein and vegf antagonist
WO2023133595A2 (en) 2022-01-10 2023-07-13 Sana Biotechnology, Inc. Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses
WO2023193015A1 (en) 2022-04-01 2023-10-05 Sana Biotechnology, Inc. Cytokine receptor agonist and viral vector combination therapies
WO2024102722A1 (en) 2022-11-07 2024-05-16 Neoimmunetech, Inc. Methods of treating a tumor with an unmethylated mgmt promoter
US20240424127A1 (en) 2023-01-11 2024-12-26 Bright Peak Therapeutics Ag Il-7 polypeptides, immunocytokines comprising same, and uses thereof
WO2024261027A1 (en) 2023-06-19 2024-12-26 Vector Biopharma Ag Il-7-retargeting of adenoviruses for cell specific infection
CN117050178B (zh) * 2023-10-13 2024-01-12 北京百普赛斯生物科技股份有限公司 特异性检测il-7的抗体及应用
WO2025093541A1 (en) 2023-10-31 2025-05-08 Ose Immunotherapeutics Combination of interleukin 7 and tumour associated antigen vaccine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA887773B (en) 1987-10-26 1989-07-26 Immunex Corp Interleukin-7
US4965195A (en) 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US5714585A (en) * 1987-10-26 1998-02-03 Sterling Winthrop, Inc. Antibodies that are immunoreactive with interleukin-7
US5328988A (en) * 1987-10-26 1994-07-12 Immunex Corporation Interleukin-7
US5153310A (en) * 1989-02-28 1992-10-06 Du Pont Merck Pharmaceutical Company Il-2 analogs containing n-linked glycosylation sites
AU2001267337A1 (en) * 2000-06-30 2002-01-14 Maxygen Aps Peptide extended glycosylated polypeptides
EP1391513A1 (en) * 2002-08-08 2004-02-25 Cytheris IL-7 drug substance, IL-7 comprising composition, preparation and uses thereof

Also Published As

Publication number Publication date
ZA200800533B (en) 2008-12-31
US20080206190A1 (en) 2008-08-28
WO2007010401A3 (en) 2007-04-19
IL188480A0 (en) 2008-04-13
EP1904635B1 (en) 2012-01-25
SI1904635T1 (sl) 2012-10-30
PL1904635T3 (pl) 2012-07-31
EA012802B1 (ru) 2009-12-30
EA200800368A1 (ru) 2008-06-30
JP2009501543A (ja) 2009-01-22
CN101228275B (zh) 2016-02-24
PT1904635E (pt) 2012-03-06
EP1746161A1 (en) 2007-01-24
AU2006271315A1 (en) 2007-01-25
US7708985B2 (en) 2010-05-04
CA2615562A1 (en) 2007-01-25
US8034327B2 (en) 2011-10-11
US8153114B2 (en) 2012-04-10
NZ564907A (en) 2011-09-30
AU2006271315B2 (en) 2011-08-11
NO344802B1 (no) 2020-05-04
HK1115154A1 (en) 2008-11-21
BRPI0613747A2 (pt) 2011-02-08
CY1112655T1 (el) 2016-02-10
CA2859145A1 (en) 2007-01-25
CN105647939A (zh) 2016-06-08
CN101228275A (zh) 2008-07-23
JP2015057392A (ja) 2015-03-26
DK1904635T3 (da) 2012-02-27
WO2007010401A2 (en) 2007-01-25
JP5685363B2 (ja) 2015-03-18
ES2379732T3 (es) 2012-05-03
US20100196312A1 (en) 2010-08-05
ATE542901T1 (de) 2012-02-15
CA2859145C (en) 2018-11-27
CA2615562C (en) 2014-11-04
EP1904635A2 (en) 2008-04-02
US20120016104A1 (en) 2012-01-19

Similar Documents

Publication Publication Date Title
NO20080045L (no) Glykosylert UL-7, fremstilling og anvendelse av samme
MX2009012650A (es) Secuencias de aminoacido dirigidas contra rank-l y polipeptidos que comprenden lo mismo para el tratamiento de enfermedades y trastornos de huesos.
ES2353814T3 (es) Proteinas n-glicosiladas recombinantes de celulas procariotas.
MX2010005783A (es) Secuencias de aminoacidos dirigidas contra citoquinas heterodimericas y/o sus receptores y polipeptidos que comprenden las mismas.
DE60330923D1 (de) Menschliche Koagulationsfaktor VII Polypeptide
WO2007104529A3 (en) Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling
MX2011008094A (es) Polipeptidos recombinantes extendidos y composiciones que comprenden los mismos.
MX2009002816A (es) Proteinas de fusion de albumina.
EP2470559A4 (en) COAGULATION FACTOR IX COMPOSITIONS AND METHODS OF MAKING AND USING THEM
TW200407425A (en) Human coagulation factor VII polypeptides
MX2009004243A (es) Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal.
DK0902085T3 (da) Rekombinant human erythropoietin med fordelagtig glycosyleringsprofil
IL212653A0 (en) Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof
ATE501728T1 (de) Therapeutische verwendung von lpi, einem inhibitor des lectinwegs in staphylokokken bei entzündungskrankheiten
HK1161887A (en) Extended recombinant polypeptides and compositions comprising same
HK1172631A (en) Coagulation factor ix compositions and methods of making and using same
BRPI0406656A (pt) Espécies de polipeptìdeos secretadas (fragmentos de quitotriosidase) reduzidas nos distúrbios cardiovasculares
DE602007009797D1 (de) Antitumorheilmittel, Medikament, Zusammensetzung und Verwendung davon
HK1172653A (en) Coagulation factor vii compositions and methods of making and using same

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees